| MDM2 |
AKT phosphorylates targets in the cytosol |
reactome |
13 |
42 |
| MDM2 |
AndrogenReceptor |
netpath |
167 |
2267 |
| MDM2 |
ATM pathway |
pid |
34 |
262 |
| MDM2 |
ATR signaling pathway |
pid |
39 |
404 |
| MDM2 |
Aurora A signaling |
pid |
33 |
119 |
| MDM2 |
Constitutive Signaling by AKT1 E17K in Cancer |
reactome |
25 |
137 |
| MDM2 |
Direct p53 effectors |
pid |
141 |
972 |
| MDM2 |
ErbB4 signaling events |
pid |
35 |
223 |
| MDM2 |
FSH |
netpath |
44 |
301 |
| MDM2 |
Glucocorticoid receptor regulatory network |
pid |
85 |
876 |
| MDM2 |
Insulin/IGF pathway-protein kinase B signaling cascade |
panther |
22 |
94 |
| MDM2 |
Oncogene Induced Senescence |
reactome |
30 |
146 |
| MDM2 |
Oxidative Stress Induced Senescence |
reactome |
120 |
3580 |
| MDM2 |
p53 pathway |
panther |
39 |
274 |
| MDM2 |
p53 pathway |
pid |
59 |
356 |
| MDM2 |
P53 pathway feedback loops 1 |
panther |
6 |
16 |
| MDM2 |
p73 transcription factor network |
pid |
80 |
478 |
| MDM2 |
Regulation of Androgen receptor activity |
pid |
54 |
338 |
| MDM2 |
Regulation of retinoblastoma protein |
pid |
67 |
718 |
| MDM2 |
Regulation of TP53 Activity through Methylation |
reactome |
19 |
77 |
| MDM2 |
Regulation of TP53 Activity through Phosphorylation |
reactome |
89 |
1144 |
| MDM2 |
Regulation of TP53 Degradation |
reactome |
35 |
257 |
| MDM2 |
Stabilization of p53 |
reactome |
9 |
35 |
| MDM2 |
Sumoylation by RanBP2 regulates transcriptional repression |
pid |
15 |
84 |
| MDM2 |
SUMOylation of transcription factors |
reactome |
14 |
57 |
| MDM2 |
Trafficking of AMPA receptors |
reactome |
17 |
88 |
| MDM2 |
Tryptophan degradation ( Tryptophan degradation ) |
inoh |
60 |
388 |
| MDM2 |
Ubiquitin proteasome pathway |
panther |
43 |
383 |
| MDM2 |
Validated transcriptional targets of deltaNp63 isoforms |
pid |
47 |
101 |
| MDM2 |
Validated transcriptional targets of TAp63 isoforms |
pid |
54 |
163 |
| MDM2 |
Cell cycle |
kegg |
124 |
2334 |
| MDM2 |
p53 signaling pathway |
kegg |
66 |
297 |
| MDM2 |
Endocytosis |
kegg |
201 |
1991 |
| MDM2 |
Pathways in cancer |
kegg |
321 |
8293 |
| MDM2 |
Glioma |
kegg |
65 |
998 |
| MDM2 |
Prostate cancer |
kegg |
85 |
1261 |
| MDM2 |
Melanoma |
kegg |
69 |
1192 |
| MDM2 |
Bladder cancer |
kegg |
38 |
233 |
| MDM2 |
Chronic myeloid leukemia |
kegg |
69 |
881 |
| MDM2 |
Hs_Cell_Cycle_WP179_89516 |
wikipathways |
33 |
97 |
| MDM2 |
Hs_ErbB_Signaling_Pathway_WP673_91869 |
wikipathways |
37 |
312 |
| MDM2 |
Hs_DNA_Damage_Response_(only_ATM_dependent)_WP710_79974 |
wikipathways |
36 |
219 |
| MDM2 |
Hs_TP53_Network_WP1742_71700 |
wikipathways |
10 |
32 |
| MDM2 |
Hs_DNA_Damage_Response_WP707_82937 |
wikipathways |
28 |
166 |
| MDM2 |
Hs_Apoptosis_WP254_88977 |
wikipathways |
31 |
127 |
| MDM2 |
Hs_Senescence_and_Autophagy_in_Cancer_WP615_81193 |
wikipathways |
62 |
254 |
| MDM2 |
Hs_Copper_homeostasis_WP3286_89205 |
wikipathways |
15 |
38 |
| MDM2 |
Hs_Bladder_Cancer_WP2828_89143 |
wikipathways |
17 |
74 |
| MDM2 |
Hs_Signaling_Pathways_in_Glioblastoma_WP2261_89520 |
wikipathways |
16 |
66 |
| MDM2 |
Hs_Retinoblastoma_(RB)_in_Cancer_WP2446_87639 |
wikipathways |
5 |
8 |
| MDM2 |
Hs_Androgen_receptor_signaling_pathway_WP138_79958 |
wikipathways |
27 |
107 |